Used in pharmaceutical research as a key intermediate in the synthesis of centrally acting agents targeting neurological disorders. Its structural features support binding to monoaminergic receptors, making it valuable in developing compounds for depression, anxiety, and cognitive dysfunction. The hydroxyl and pyrrolidine groups allow further chemical modifications, enabling optimization of pharmacokinetic properties such as blood-brain barrier penetration and metabolic stability. Also explored in structure-activity relationship (SAR) studies to enhance selectivity and potency of new therapeutic candidates.